Skip to main content
TTrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Clinical Trials in New Jersey

231 recruiting clinical trials across 15 cities in New Jersey (NJ). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
231
Total Trials
231
Recruiting Now
15
Cities
20
Conditions

Recruiting Trials in New Jersey

Clinical trial data sourced from ClinicalTrials.gov. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 3NCT01804686

A Long-term Extension Study of PCI-32765 (Ibrutinib)

The purpose of this study is to collect long-term safety and efficacy data for participants treated with ibrutinib and to provide ongoing access to ibrutinib for participants who...

Sponsor: Janssen Research & Development, LLCEnrolling: 70020 locations
Chronic Lymphocytic LeukemiaSmall Lymphocytic LymphomaMantle Cell Lymphoma+4
RECRUITINGNCT01905709

Fecal Microbiota Transplantation for C Diff Infection

The objective of this study is to provide treatment with Fecal Microbiota Transplantation (FMT) to patients with recurrent or refractory Clostridium difficile infection (CDI). It...

Sponsor: Englewood Hospital and Medical CenterEnrolling: 1001 location
Clostridium Difficile Infection
RECRUITINGPhase 1 / Phase 2NCT02343042

Selinexor and Backbone Treatments of Multiple Myeloma Patients

This study will independently assess the efficacy and safety of 11 combination therapies in 12 arms, in dose-escalation/-evaluation and expansion phases, for the treatment of...

Sponsor: Karyopharm Therapeutics INCEnrolling: 30020 locations
Multiple Myeloma
RECRUITINGPhase 1NCT03178149

A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due...

Age-related macular degeneration (AMD) is an eye disease which causes people to lose their sharp central vision over time. Aging damages the macula, which is in the middle of the...

Sponsor: Astellas Institute for Regenerative MedicineEnrolling: 4219 locations
Age-Related Macular Degeneration
RECRUITINGNCT03334708

A Study of Blood Based Biomarkers for Pancreas Adenocarcinoma

The purpose of this study is to develop a minimally invasive test to diagnose pancreatic cancer at early stages of disease and monitor response to treatment.

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 70013 locations
Pancreatic CancerPancreatic DiseasesPancreatitis+1
RECRUITINGNCT03392337

An Open-Label, Pilot Study to Evaluate the Efficacy of Narrowband Ultraviolet-B Phototherapy Three Times Weekly for...

A single center study of 30 patient receiving Narrowband UVB phototherapy three times weekly for 12 weeks. Patients will be evaluated through week 36 to evaluate maintenance of...

Sponsor: Psoriasis Treatment Center of Central New JerseyEnrolling: 301 location
Psoriasis
RECRUITINGPhase 3NCT03401398

Stress Hydrocortisone In Pediatric Septic Shock

SHIPSS is a multi-institutional, prospective, controlled, randomized, double-blinded interventional trial that will examine the potential benefits and risks of adjunctive...

Sponsor: Jerry ZimmermanEnrolling: 50020 locations
Septic Shock
RECRUITINGPhase 1 / Phase 2NCT03556228

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

This is a multicenter, open-label, Phase 1/2 study of orally administered VMD-928 monotherapy and in combination with pembrolizumab in adult subjects with advanced solid tumors or...

Sponsor: VM Oncology, LLCEnrolling: 24215 locations
Head and Neck CarcinomaAdenoid Cystic CarcinomaLung Cancer+22
RECRUITINGPhase 1 / Phase 2NCT03761108

Phase 1/2 Study of Linvoseltamab in Adult Patients With Relapsed or Refractory Multiple Myeloma

The main purpose of this study is to learn about the safety of linvoseltamab and to find out what is the best dose of linvoseltamab to give to patients with multiple myeloma and...

Sponsor: Regeneron PharmaceuticalsEnrolling: 38720 locations
Multiple Myeloma
RECRUITINGPhase 2NCT03808337

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for...

This study is being done to determine if stereotactic body radiotherapy (SBRT) when delivered to all sites of disease in participants with 1-5 metastases will increase the length...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 14512 locations
Triple Negative Breast CancerNon Small Cell Lung CancerMetastatic Breast Cancer+1
RECRUITINGPhase 4NCT03827876

Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

4 weeks of adjunctive therapy of Enstilar® QD followed by 12 weeks QOD to patients with 2-10% BSA who are receiving etanercept or adalimumab for at least 24 weeks

Sponsor: Psoriasis Treatment Center of Central New JerseyEnrolling: 301 location
Psoriasis
RECRUITINGPhase 1NCT03909412

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

This phase I study utilizes a 3+3 design with escalating cohorts of Carfilzomib at 20mg/m2, 27mg/m2, 36mg/m2, 45mg/m2, 56mg/m2, and 70mg/m2 to be administered concomitantly with...

Sponsor: Hackensack Meridian HealthEnrolling: 181 location
Multiple Myeloma
RECRUITINGPhase 2 / Phase 3NCT04011020

Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes

Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that causes a deficit of pancreatic islet beta cells. Millions of individuals worldwide have T1D, and incidence...

Sponsor: Throne Biotechnologies INC.Enrolling: 502 locations
Type 1 Diabetes
RECRUITINGPhase 2NCT04015141

A Study to Evaluate Efficacy and Safety of Perampanel Administered as an Adjunctive Therapy in Pediatric Participants...

The purpose of the study is to evaluate the efficacy of perampanel as measured by the 50 percent (%) responder rate during the maintenance period of the core study for seizure...

Sponsor: Eisai Inc.Enrolling: 10020 locations
Pediatric Epileptic SyndromePartial-onset Seizures
RECRUITINGPhase 2NCT04084730

Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

The purpose of this study is to determine if the dose of radiation therapy that is effective in producing a treatment response, delivered over a shorter treatment period, is a...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 2809 locations
Invasive Ductal Breast CarcinomaInvasive Ductal Carcinoma, BreastDCIS+3
RECRUITINGPhase 1 / Phase 2NCT04094610

A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

Phase 1 will evaluate the safety and tolerability at different dose levels of repotrectinib in pediatric and young adult subjects with advanced or metastatic malignancies...

Sponsor: Turning Point Therapeutics, Inc.Enrolling: 7520 locations
Locally Advanced Solid TumorsMetastatic Solid TumorsLymphoma+1
RECRUITINGPhase 1 / Phase 2NCT04104776

A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas

The purpose of this open-label, first-in-human (FIH) trial is to evaluate the safety, tolerability, and preliminary clinical activity of Tulmimetostat as a monotherapy in patients...

Sponsor: Novartis PharmaceuticalsEnrolling: 27520 locations
Advanced Solid TumorDiffuse Large B Cell LymphomaLymphoma, T-Cell+5
RECRUITINGPhase 4NCT04160000

Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure

Heart failure (HF) with preserved left ventricular function (pEF) is difficult clinical syndrome to treat effectively with few evidence based therapies. Atrial fibrillation (AF)...

Sponsor: Electrophysiology Research FoundationEnrolling: 3609 locations
Atrial FibrillationHeart FailureDiastolic Heart Failure
RECRUITINGPhase 1 / Phase 2NCT04278131

BS01 in Patients With Retinitis Pigmentosa

A Phase 1/2, Safety and Efficacy Trial of BS01, a Recombinant Adeno-Associated Virus Vector Expressing ChronosFP (AAV2-CAG-ChronosFP) in Patients with Retinitis Pigmentosa

Sponsor: Bionic Sight LLCEnrolling: 201 location
Retinitis Pigmentosa
RECRUITINGPhase 4NCT04347473

ILUMYA in Combination With HALOG Ointment 0.1% for Plaque Psoriasis.

Patient with moderate-to-severe plaque psoriasis will receive Ilumya with or without Halog ointment.

Sponsor: Psoriasis Treatment Center of Central New JerseyEnrolling: 251 location
Psoriasis
RECRUITINGPhase 4NCT04372277

Taltz in Combination With Enstilar for Psoriasis

Enstilar in combination with Taltz for plaque psoriasis.

Sponsor: Psoriasis Treatment Center of Central New JerseyEnrolling: 251 location
Psoriasis
RECRUITINGPhase 2NCT04594187

Nodal Radiation Therapy for Sentinel Lymph Node Positive Melanoma

This phase II trial seeks to determine the role of nodal radiation therapy after sentinel lymph node biopsy (SLNB) for patients with high risk sentinel lymph node positive...

Sponsor: M.D. Anderson Cancer CenterEnrolling: 1683 locations
Melanoma
RECRUITINGNCT04656496

NOURISH-T+: Promoting Healthy Eating and Exercise Behaviors

Pediatric cancer survivors are at an increased risk of excessive weight gain and reduced exercise behaviors with the potential for this risk to worsen over time. With over 80% of...

Sponsor: University of South FloridaEnrolling: 52010 locations
Obesity, ChildhoodCancerSurvivorship
RECRUITINGNCT04682483

Cardiogenic Shock Working Group Registry

The Cardiogenic Shock Working Group is a multicenter registry where we collect de-identified clinical variables from the medical records and follow-up phone calls of shock...

Sponsor: Tufts Medical CenterEnrolling: 500016 locations
Cardiogenic Shock
RECRUITINGNCT04739072

Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

This study investigates if circulating tumor DNA (ctDNA) and other tumor-related molecules/chemicals released in the blood can help doctors predict if colorectal cancer may come...

Sponsor: M.d. Anderson Cancer CenterEnrolling: 100010 locations
Colorectal AdenocarcinomaStage I Colorectal Cancer AJCC v8Stage II Colorectal Cancer AJCC v8+11
RECRUITINGPhase 3NCT04779320

A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)

Vedolizumab is a medicine that helps to reduce inflammation and pain in the digestive system. In this study, children and teenagers with moderate to severe Crohn's disease will be...

Sponsor: TakedaEnrolling: 12020 locations
Crohn's Disease (CD)
RECRUITINGNCT04855825

Investigating the Effects of Wearable Robotic Exoskeleton for Improving Mobility and Cognition in Persons With MS

The purpose of this research study is to evaluate the usefulness of a wearable robotic exoskeleton device (Ekso-GT), to improve learning and memory, and gait therapy in persons...

Sponsor: Kessler FoundationEnrolling: 101 location
Multiple SclerosisGait Disorders, NeurologicMotility Disorder+1
RECRUITINGPhase 2NCT04862468

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Acute...

This is a study of a medical procedure that utilizes a commercially available catheter (the Bullfrog® Micro-Infusion Device) to locally deliver a commercially available...

Sponsor: Mercator MedSystems, Inc.Enrolling: 8017 locations
Thrombosis, Deep VeinIliofemoral; Thrombosis
RECRUITINGPhase 3NCT04878094

A Study of Intra-operative Imaging in Women With Ovarian Cancer

The purpose of this study is to find out whether using the PINPOINT imaging system intra-operatively can reduce the risk of anastomotic leaks and other complications after surgery...

Sponsor: Memorial Sloan Kettering Cancer CenterEnrolling: 3109 locations
Ovarian CancerOvarian Carcinoma
RECRUITINGNCT04929899

Bright Ideas - CIN Feasibility Study

In this study investigators will determine the feasibility of a future trial comparing chemotherapy-induced nausea control in children with ALL receiving oral 6-mercaptopurine who...

Sponsor: The Hospital for Sick ChildrenEnrolling: 754 locations
Acute Lymphoblastic Leukemia (ALL)

Showing 30 of 231 trials in New Jersey. Search all trials

Browse Trials by State

Frequently Asked Questions

There are currently 231 clinical trials actively recruiting participants in New Jersey. These span all phases from early-stage Phase 1 to late-stage Phase 3 trials, across 20+ conditions.

The top conditions with recruiting trials in New Jersey include Multiple Myeloma, Schizophrenia, Psoriasis, Mesothelioma, Melanoma. Each has multiple active trials across research centers in the state.

Major trial sites in New Jersey include New Brunswick, Hackensack, Middletown, Montvale, Basking Ridge. Most large academic medical centers and research hospitals serve as trial sites.

Review the trial listings on this page and check the eligibility criteria — we translate them into plain English. When you find a trial that fits, talk to your doctor about whether it's right for you, then contact the trial team directly using the information on the trial page.

Sources: ClinicalTrials.gov
Last updated:

Trial data sourced from the ClinicalTrials.gov API. Location data reflects registered trial sites. This site does not provide medical advice.